Applied DNA Sciences Files 10-Q for March 31, 2025
Ticker: BNBX · Form: 10-Q · Filed: May 15, 2025 · CIK: 744452
Sentiment: neutral
Topics: 10-Q, financials, disclosure
TL;DR
APDN 10-Q filed for Q1 2025. Financials and ops update.
AI Summary
Applied DNA Sciences Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Specific financial figures and operational details for the quarter are detailed within the filing.
Why It Matters
This filing provides investors and stakeholders with a crucial update on Applied DNA Sciences' financial health and operational performance for the most recent quarter.
Risk Assessment
Risk Level: medium — 10-Q filings are standard disclosures, but the specific financial health and operational details within this report will determine the actual risk level.
Key Numbers
- 0.05 — Fair Value Adjustment of Warrants (Indicates changes in the valuation of outstanding warrants.)
- 0.20 — Additional Paid-In Capital (Represents capital raised from stock issuance above par value.)
- 0.02 — Direct Offering (Likely related to capital raised through a direct offering.)
- 0.02 — At Market Offering (Likely related to capital raised through an at-the-market offering.)
Key Players & Entities
- APPLIED DNA SCIENCES INC (company) — Filer
- 0000744452 (company) — Central Index Key
- 20250331 (date) — Period of Report
- 20250515 (date) — Filed as of Date
- STONY BROOK (location) — Business Address City
- NY (location) — Business Address State
- 11790 (location) — Business Address Zip
FAQ
What were the total revenues for the quarter ending March 31, 2025?
The provided text does not contain specific revenue figures for the quarter ending March 31, 2025.
What is the company's net income or loss for the period?
The provided text does not specify the net income or loss for the period ending March 31, 2025.
How much cash and cash equivalents does Applied DNA Sciences have as of March 31, 2025?
Specific figures for cash and cash equivalents are not detailed in the provided text.
What were the significant changes in the company's debt structure during the quarter?
Information regarding changes in the company's debt structure is not present in the provided text.
What are the company's forward-looking statements or guidance for the next fiscal quarter?
The provided text does not include forward-looking statements or guidance for the upcoming fiscal quarter.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding APPLIED DNA SCIENCES INC (BNBX).